DuPont MBR System Selected for Canberra Upgrade
DuPont MBR system with approximately 97 million liters per day capacity will support the Lower Molonglo wastewater plant expansion in Canberra.
DuPont has been selected to supply a membrane bioreactor system with capacity of about 97 million liters a day for an expansion of the Lower Molonglo Water Quality Control Centre in Canberra, Australia. The project will make the site Australia’s largest MBR plant and expand treatment capacity at the country’s largest inland wastewater treatment facility. Icon Water owns and operates the plant, which serves as the primary wastewater treatment facility for the Australian Capital Territory. Seymour Whyte and VINCI Construction Grands Projects are collaborating on the upgrade, which adds a secondary treatment process based on membrane technology.
Capacity Expansion for Canberra
The Lower Molonglo Water Quality Control Centre has operated since the late 1970s. Its expansion is intended to meet demand associated with Canberra’s population growth while maintaining high-quality effluent for safe discharge.
DuPont’s MemCor™ membrane bioreactor system will sit at the center of the new secondary treatment process. The system has a treatment capacity of approximately 97 million liters per day, enhancing the plant’s ability to serve the Canberra region while supporting future growth.
Matthew Dick, Business Development & Sales Manager at DuPont Water Solutions, said:
“We're proud to support this landmark project with a MemCor™ MBR system that is manufactured here in Australia. It illustrates how DuPont combines its global innovation capabilities with local expertise to provide reliable and scalable wastewater treatment solutions for growing communities.”
Membrane Treatment System
For over 30 years, MemCor™ MBR systems with MemPulse™ modules have established a reputation for high efficiency, reliability, and reduced operational costs in hundreds of municipal and industrial installations worldwide.
The Canberra project adds membrane-based secondary treatment to a facility that will continue to serve the Australian Capital Territory as the region grows.
